Orifarm
From Wikipedia, the free encyclopedia
| Formation | 1994 |
|---|---|
| Founder | Brigitte and Hans Bøgh-Sørensen |
| Headquarters | Odense, Denmark |
| Subsidiaries | Pilatus Comparator Solutions |
| Website | www.orifarm.com |
Orifarm (founded 1994) is a Danish pharmaceutical company[1][2] based in Odense.[3][4][5]
Orifarm is a family-owned company established in 1994 by Hans Bøgh-Sørensen and his wife Birgitte Bøgh-Sørensen.[6][7]
Orifarm entered the market in 1995 with a portfolio of 25 products and 9 employees. Since then, the company has experienced significant growth and currently employs approximately 2,200 persons across multiple locations in Europe and the United States.[8]
In 1997, Orifarm expanded into Sweden, marking its first presence in a European market beyond Denmark. By 2014, Orifarm entered the Dutch market, establishing its sixth sales office in Europe.[9][10]
In 2019, Orifarm extended its operations beyond Europe by acquiring Pilatus Comparator Solutions, a company active in the United Kingdom, Germany, and the United States.[11]
In 2020, the company bought a part of Takeda Pharmaceutical Company (Japan) and the[3][12][13] rights to a number of over-the-counter and prescription medicines for DKK 4.6 billion (670 million USD).[14][15] Through this acquisition, Orifarm also gained control of two production facilities in Łyszkowice, Poland, and Hobro, Denmark.[16]
In 2021, the company’s revenue increased by 27% to DKK 10.54 billion (EUR 1,417 billion). Operating profit also rose by 39%, reaching DKK 413 million (EUR 55.3 million).[17]
References
- ↑ "101 Top Health Care Startups and Companies in Denmark (2021)".
- ↑ "PIL error: Orifarm Concerta XL | Dispensing Doctor Association". www.dispensingdoctor.org. Retrieved 2024-03-26.
- 1 2 Tirumalaraju, Divya (2020-04-24). "Takeda to sell OTC and non-core assets to Orifarm for $670m". Pharmaceutical Technology. Retrieved 2024-03-26.
- ↑ "Information management platform startup M-Files raises $80M". SiliconANGLE. 2021-01-12. Retrieved 2024-03-26.
- ↑ "Takeda Sells OTC Drugs to Denmark's Orifarm | CHEManager". www.chemanager-online.com. Retrieved 2024-03-26.
- ↑ "The year our onboarding reached new heights - Orifarm". www.orifarm.com. Retrieved 2024-03-26.
- ↑ "How an acquisition helped Orifarm prepare a prescription for growth". www.ey.com. Retrieved 2024-03-26.
- ↑ "Orifarm ansætter flere og bygger nyt: Milliard-opkøb af japansk gigant var en større mundfuld end ventet | fyens.dk". fyens.dk (in Danish). 2022-04-19. Retrieved 2024-07-01.
- ↑ "How an acquisition helped Orifarm prepare a prescription for growth". www.ey.com. Retrieved 2024-03-26.
- ↑ "Ny direktør bestod: Fynske Orifarm har aldrig tjent mere | fyens.dk". fyens.dk (in Danish). 2019-05-29. Retrieved 2024-03-26.
- ↑ "Orifarm has high hopes for new business arm - may be the key to the US market". medwatch.dk (in Danish). 2020-03-25. Retrieved 2024-07-01.
- ↑ Nawrat, Allie (2020-04-28). "Takeda-Orifarm deal: another divestiture for the Japanese pharma giant". Pharmaceutical Technology. Retrieved 2024-03-26.
- ↑ Wessel, Lene (2022-06-10). "HR-direktør om onboarding af 900 medarbejdere: "Hold øje med de bløde ting" | PeopleTech (PRO)". ing.dk (in Danish). Retrieved 2024-03-26.
- ↑ "Konkurrencerådet griber ind i Orifarms overtagelse af dele af Takeda". www.kfst.dk (in Danish). 2021-03-24. Retrieved 2024-03-26.
- ↑ "Large multimillion Euro acquisition - Orifarm". www.orifarm.com. Retrieved 2024-03-26.
- ↑ "Orifarm køber lægemidler og fabrikker af Takeda for 4,6 mia. kr". medwatch.dk (in Danish). 2020-04-24. Retrieved 2024-07-01.
- ↑ "Orifarm i stor fremgang - omsætningen runder 10 mia. kr". medwatch.dk (in Danish). 2022-07-04. Retrieved 2024-07-01.
Media related to Orifarm at Wikimedia Commons